Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 4 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 12018074

    Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseases

    CHEMOMAB LTD. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  2. US 12005036

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  3. US 12005080

    Method for promoting proliferation of immune cells

    Oricell Therapeutics Co., Ltd. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  4. US 12005123

    Conjugate of isotretinoin and peptide

    CAREGEN CO., LTD. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  5. US 11998571

    Pharmaceutical composition comprising stem cell-conditioned medium and exosome isolated therefrom as active ingredient for prevention or treatment of ocular disease

    DESIGNED CELLS CO., LTD. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  6. US 11999748

    Exatecan derivatives, linker-payloads, and conjugates and thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  7. US 11998639

    Formulations of (R)-2-amino-3-phenylpropyl carbamate

    AXSOME MALTA LTD. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  8. US 11993655

    Anti-PD-L1 antibody and use thereof

    Oricell Therapeutics Co., Ltd. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  9. US 11986455

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  10. US 11986454

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  11. US 11969404

    Methods of providing solriamfetol therapy to subjects with impaired renal function

    AXSOME MALTA LTD. · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  12. US 11970479

    3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor

    MSD R&D (China) Co. Ltd. · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted
  13. US 11931463

    All-in-one fixed-dose combination for treating Helicobacter pylori infection

    RedHill Biopharma Ltd. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  14. US 11932617

    Compound for use in retinal diseases

    ZHUHAI UNITED LABORATORIES CO., LTD. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  15. US 11933866

    Magnetic resonance maps for analyzing brain tissue

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  16. US 11932653

    Lycorine derivative, and pharmaceutical composition and use thereof

    BEIJING DYNE HIGH-TECH PEDIATRIC PHARMACEUTICAL R&D INSTITUTE CO., LTD. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  17. US 11925669

    Chinese herbal medicine composition having a function of reducing uric acid

    INFINITUS (CHINA) COMPANY LTD. · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  18. US 11925686

    Materials for phototherapies of ophthalmic diseases

    EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD. · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  19. US 11919933

    Use of MYOG gene as target in preparation of drug for treating cardiomyocyte apoptosis-associated cardiovascular disease

    GUANGDONG BEATING ORIGIN REGENERATIVE MEDICINE CO., LTD. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  20. US 11918620

    Traditional Chinese medicine composition, and preparation method therefor and application thereof

    Suzhou Regen-PharmaTech Co., Ltd. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  21. US 11918560

    Serine protease inhibitor for treating coronavirus infection

    RedHill Biopharma Ltd. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  22. US 11919896

    [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof

    ZHUHAI UNITED LABORATORIES CO., LTD. · Granted Mar 5, 2024 · Expires Feb 29, 2044

    granted
  23. US 11911435

    Stable antibody-drug conjugate, preparation method therefor, and use thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  24. US 11911434

    Stable antibody-drug conjugate, preparation method therefor, and use thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted